StonvexLoading…
StonvexStonvexStonvexCore line items from FTRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $636.50M | $2.72B | $2.06B | $1.36B |
Operating Income | $-3.40M | $-872.60M | $-859.00M | $-850.40M |
Net Income | $-23.60M | $-986.20M | $-953.70M | $-374.90M |
EPS (Diluted) | $-0.25 | $-10.81 | $-10.53 | $-10.37 |
Total Assets | $2.68B | $2.72B | $2.74B | $2.84B |
Total Liabilities | $2.16B | $2.15B | $2.16B | $2.25B |
Cash & Equivalents | $147.50M | $174.60M | $131.30M | $81.20M |
Free Cash Flow OCF − CapEx | $-25.00M | $88.30M | $-33.30M | $-112.80M |
Shares Outstanding | 94.60M | 93.10M | 92.20M | 90.80M |